Associate Professor of Urology, University Wash
Urology
Dr. Thomas K. Takayama, MD
|
|
Give Review
Thomas Takayama works in the field of Urology. He went to medical school at Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He received 2 awards: "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Thomas K. Takayama, MD is also a published physician. He has 17 publication published. The most recent publication is: Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma. Doctor Thomas K. Takayama, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Protease-activated receptor 2 signaling upregulates angiogenic growth factors in Renal cell carcinoma.
- Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate Cancer through protease-activated receptor-1.
- Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
- Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate Cancer and bone metastasis.
- Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
- Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate Cancer cells through protease-activated receptors-1 and -2.
- Regulated expression of active biotinylated G-protein coupled receptors in mammalian cells.
- Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
- Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate Cancer.
- Two-year outcome of unilateral sural nerve interposition graft after radical Prostatectomy.
- Substrates of the Prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
- Extensive palliative surgery for advanced mesothelioma of the tunica vaginalis.
- Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
- Imaging primary and secondary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging.
- Preoperative planning for Renal cell carcinoma--benefits of 64-slice CT imaging.
- Gene expression down-regulation in CD90+ Prostate tumor-associated stromal cells involves potential organ-specific genes.
Schools
Tufts University School Of Medicine
Mt Zion Hospital
University Mass
University of Washington
Procedures Preformed
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Washington -
Tufts University School of Medicine
Hospital
-
Overlake Medical Center -
Swedish Medical Center-Cherry Hill Campus -
EvergreenHealth
Drug Facts
| NPI NUMBER | 1720166184 | |
| NPPES Provider LastName | TAKAYAMA | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 980044623 | |
| NPPES Provider State | WA | |
| Specialty Description | Urology | |
| Total Claim Count | 300.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 8.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720166184 |
| Last Name Of The Provider | TAKAYAMA |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Kathleen C. Kobashi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jian F. Ma, MD |
|
|
Dr. George E. Dueker, MD |
|
|
Dr. Robert M. Weissman, MD |
|
|
Dr. Francis J. Schumann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Una J. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin J. Wall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. McEvoy, MD |